HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suture-based vs. pure plug-based vascular closure devices for VA-ECMO decannulation-A retrospective observational study.

AbstractBackground:
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a valuable treatment option for patients in cardiogenic shock, but complications during decannulation may worsen the overall outcome. Therefore, the aim of this study was to compare the efficacy and safety of suture-based to pure plug-based vascular closure devices for VA-ECMO decannulation.
Methods:
In this retrospective study, the procedural outcome of 33 patients with suture-based Perclose ProGlide closure devices was compared to 38 patients with MANTA plug-based closure devices.
Results:
Rate of technically correct placement of closure devices was 88% in the suture-based group and 97% in the plug-based group (p = 0.27). There was a significant reduction of severe bleeding events during VA-ECMO decannulation in plug-based versus suture-based systems (3% vs. 21%, p = 0.04). Ischemic complications occurred in 6% with suture-based and 5% with plug-based device (p = 1.00). Pseudoaneurysm formation was detected in 3% in both groups (p = 1.00). No switch to vascular surgery due to bleeding after decannulation was necessary in both groups.
Conclusion:
Based on our retrospective analysis, we propose that plug-based vascular closure should be the preferred option for VA-ECMO decannulation. This hypothesis should be further tested in a randomized trial.
AuthorsClemens Scherer, Hans Theiss, Mario Istrefi, Leonhard Binzenhöfer, Danny Kupka, Thomas Stocker, Enzo Lüsebrink, Era Stambollxhiu, Ahmed Alemic, Tobias Petzold, Konstantin Stark, Simon Deseive, Daniel Braun, Dominik Joskowiak, Sven Peterss, Jörg Hausleiter, Christian Hagl, Steffen Massberg, Martin Orban
JournalFrontiers in cardiovascular medicine (Front Cardiovasc Med) Vol. 10 Pg. 1106114 ( 2023) ISSN: 2297-055X [Print] Switzerland
PMID36776253 (Publication Type: Journal Article)
CopyrightCopyright © 2023 Scherer, Theiss, Istrefi, Binzenhöfer, Kupka, Stocker, Lüsebrink, Stambollxhiu, Alemic, Petzold, Stark, Deseive, Braun, Joskowiak, Peterss, Hausleiter, Hagl, Massberg and Orban.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: